RAPT Therapeutics Inc — Cash Flow (NASDAQ:RAPT) | MetaTrader

Open full chart

Financials

Overview 声明 Statistics

Quarterly Annual

Cash from operating activities 40.49 M61 M70.8 M97 M83.3 M 86.58 M Cash from investing activities 87.44 M81.35 M45.49 M104.13 M52.7 M 55.02 M Cash from financing activities 75.46 M141.48 M131.18 M1.45 M152.85 M 143.31 M Free cash flow 40.09 M60.24 M69.95 M95.88 M83.18 M 86.5 M

新闻

GSK完成22亿美元收购RAPT Therapeutics交易

GSK completes $2.2 billion acquisition of RAPT Therapeutics

RAPT Therapeutics股价触及52周高点57.98美元

RAPT Therapeutics stock hits 52-week high at $57.98

Rapt Therapeutics股价触及52周高点57.87美元

Rapt Therapeutics stock hits 52-week high at 57.87 USD

从实验室到股市飙升：富国银行选出2026年SMID-Cap生物科技领军股

GSK财报即将公布，投资者关注新CEO的管线战略

Rapt Therapeutics股票达到52周高点57.71美元

Rapt Therapeutics stock reaches 52-week high at $57.71

GSK to Boost Respiratory & Immunology Pipeline With $2.2B RAPT Buyout

RAPT Therapeutics股价触及52周新高57.62美元